Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells
- PMID: 1355757
- DOI: 10.1002/ijc.2910520217
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells
Abstract
Two new human cholangiocarcinoma (CC) cell lines (CC-SW-I and CC-LP-I) were established and maintained in culture for 2 years. Histologically, both original liver tumors were adenocarcinomas, and the cell lines exhibited morphologic features of moderately differentiated adenocarcinoma. Immunohistochemistry showed that both cell lines were strongly positive for cytokeratin AEI but negative for carbohydrate tumor-associated antigen, CA19-9. Ultrastructural analysis of both cell lines showed the presence of tight junctional complexes and focally formed microvilli. Both CC cell lines were tumorigenic in nude mice. Cytogenetic analysis showed that both cell lines expressed highly aneuploid karyotypes with numerous structural and numerical deviations. CC-SW-I was hypodiploid with numerous chromosome losses and structural rearrangements, while CC-LP-I was hyperdiploid and displayed multiple additional chromosomes. Doubling times for the CC-SW-I and CC-LP-I cell lines in the presence of 15% fetal bovine serum were 72 hr and 180 hr, respectively. Growth of the CC-SW-I cell line was significantly stimulated in the presence of insulin, while that of the CC-LP-I cell line was significantly augmented by epidermal growth factor (EGF). In contrast, dexamethasone strongly inhibited proliferation of both cell lines in a dose-dependent manner. Among various recombinant cytokines examined for effects on growth or surface antigen expression on CC cell lines, only interleukin I-beta (ILI-beta) strongly inhibited growth of the CC-LP-I cell line, while interferons (IFNs) or tumor necrosis factor-alpha (TNF-alpha) were mildly inhibitory. Both tumor cell lines were resistant to natural killer (NK) cells but sensitive to lymphokine-activated killer (LAK) cells. Preincubation of tumor cells with IFN-gamma, IFN-alpha or TNF-alpha significantly decreased the susceptibility of each tumor cell line to lysis by LAK cells, and the change in sensitivity did not correlate with the expression of HLA antigens or intercellular adhesion molecule-I (ICAM-I) on the surface of tumor cells. These 2 CC cell lines are expected to provide valuable information about cell biology of human CC.
Similar articles
-
Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.Cancer Biother Radiopharm. 1997 Oct;12(5):317-31. doi: 10.1089/cbr.1997.12.317. Cancer Biother Radiopharm. 1997. PMID: 10851482
-
[LAK sensitivity of human pancreas carcinoma cell lines].Hokkaido Igaku Zasshi. 1993 Nov;68(6):921-34. Hokkaido Igaku Zasshi. 1993. PMID: 7906667 Japanese.
-
Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
-
Interferon--a major regulator of natural killer cell-mediated cytotoxicity.J Interferon Res. 1993 Aug;13(4):247-57. doi: 10.1089/jir.1993.13.247. J Interferon Res. 1993. PMID: 7693829 Review.
Cited by
-
Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.World J Gastroenterol. 2006 Oct 28;12(40):6500-6. doi: 10.3748/wjg.v12.i40.6500. World J Gastroenterol. 2006. PMID: 17072981 Free PMC article.
-
Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.World J Gastroenterol. 2010 Jan 14;16(2):156-66. doi: 10.3748/wjg.v16.i2.156. World J Gastroenterol. 2010. PMID: 20066734 Free PMC article.
-
Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA.World J Gastroenterol. 2011 Jun 28;17(24):2924-32. doi: 10.3748/wjg.v17.i24.2924. World J Gastroenterol. 2011. PMID: 21734803 Free PMC article.
-
MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.Gastroenterology. 2012 Jul;143(1):246-56.e8. doi: 10.1053/j.gastro.2012.03.045. Epub 2012 Apr 3. Gastroenterology. 2012. PMID: 22484120 Free PMC article.
-
15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.J Biol Chem. 2013 Jul 5;288(27):19484-502. doi: 10.1074/jbc.M113.453886. Epub 2013 May 16. J Biol Chem. 2013. Retraction in: J Biol Chem. 2015 Nov 20;290(47):28353. doi: 10.1074/jbc.A113.453886. PMID: 23687300 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials